MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST001121/mwtabprimaryOK200Mass SpectrometryESIInterstitial Cystitishttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST001121Condition:Interstitial cystitisUrineCSH POSITIVE ION MODE.MetabolomicsWorkbenchMetabolomicsHomo SapiensUniversity of California, DavisPC(35:1) [M+H]+DG 43:4; [M+NH4]+PA 8:0; [M+Na]+PC 6:0; [M+H]+TG(52:2) [M+Na]+PA 27:4; [M+Na2-H]+SM(d42:1) [M+H]+PE(36:4)[M+H]+PE 6:0; [M+H]+PS 19:1; [M+H]+PE 36:2; [M+Na]+PC(o-34:0) [M+H]+TG 48:2; TG(16:0/16:1/16:1); [M+Na]+AC 14:1; [M]+PC(36:1) [M+H]+PS 21:0; [M+H]+DG 40:3; [M+NH4]+PA 41:5; [M+Na2-H]+plasmenyl-PC 36:1; [M+H]+lysoPC 22:2; [M+Na]+TG(54:6) A [M+Na]+CerP 18:0; [M+H]+PC 7:0; [M+H]+AC 16:3; [M]+LysoPE 17:1; [M+H]+TG 52:3; TG(16:0/18:1/18:2); [M+Na]+PG 34:0; PG(17:0/17:0); [M+NH4]+lysoPC 8:0; [M+H]+TG(54:5) A [M+Na]+PC(40:5) A [M+H]+lysoPC 7:0; [M+H]+TG(56:1) [M+NH4]+EtherPC 34:1e; PC(14:0e/20:1); [M+H]+DG 32:4; [M+NH4]+PG 33:1; PG(16:0/17:1); [M+NH4]+TG(51:1) [M+NH4]+TG(58:1) [M+NH4]+PE(p-36:4)/PE(o-36:5) [M+H]+TG(57:1) [M+NH4]+PE(38:6)[M+H]+DG 38:4; [M+NH4]+PS 6:0; [M+Na]+PE 4:0; [M+Na]+TG(51:2) [M+Na]+TG(52:0) [M+Na]+PA 7:0; [M+Na]+PC(34:1) [M+H]+TG(53:1) [M+NH4]+PC 6:0; [M+Na]+PA 23:1; [M+Na2-H]+PE 36:4; [M+Na]+AC 5:0; [M]+SM(d41:1) [M+H]+PC 34:2; PC(16:0/18:2); [M+H]+MG 22:5; [M+NH4]+TG(53:2) [M+Na]+CE(16:1) [M+Na]+PC(34:3) B [M+H]+TG 50:3; TG(16:0/16:1/18:2); [M+Na]+PC 31:1; [M+H]+CerP 20:1; [M+H]+AC 18:0; [M]+PC 17:0; [M+H]+PC(36:3) B [M+H]+plasmenyl-PE 37:0; [M+Na]+lysoPC 5:0; [M+H]+MG 20:4; [M+NH4]+TG(59:2) [M+NH4]+EtherPE 36:2e; PE(18:0e/18:2); [M+H]+TG(54:1) [M+Na]+AC 16:4; [M]+DG 38:2; [M+NH4]+TG(53:3) [M+Na]+PC(34:0) [M+H]+TG 54:5; TG(18:1/18:2/18:2); [M+Na]+MG 22:4; [M+NH4]+PE(p-38:4)/PE(o-38:5) [M+H]+AC(10:0) [M+H]+TG(57:2) [M+NH4]+TG 50:2; TG(16:0/16:1/18:1); [M+Na]+PA 26:1; [M+Na]+TG 46:2; [M+NH4]+SM(d42:3) [M+H]+PC 29:6; [M+Na]+PE(p-36:2)/PE(o-36:3) [M+H]+PE(38:4)[M+H]+PE 36:3; [M+Na]+PC 8:0; [M+H]+CerP 21:1; [M+H]+SM(d40:1) [M+H]+TG(50:1) [M+Na]+MG 18:0; [M+NH4]+lysoPE 21:0; [M+H]+PC(36:2) [M+H]+TG(52:1) [M+Na]+CerP 16:0; [M+H]+PC(p-38:3)/PC(o-38:4) B [M+H]+TG(54:0) [M+NH4]+SM(d38:1) [M+H]+TG(48:0) [M+Na]+TG(50:0) [M+Na]+AC 19:5; [M]+TG 54:5; [M+NH4]+PC(38:6) B [M+H]+SM 24:0; [M]+MG 22:1; [M+NH4]+TG 60:4; [M+NH4]+PE 36:1; PE(18:0/18:1); [M+H]+plasmenyl-PC 33:0; [M+Na]+PC 29:0; [M+H]+MG 20:1; [M+NH4]+PC 33:2; [M+H]+PC 24:1; [M+Na]+AC 12:3; [M]+lysoPC 10:0; [M+Na]+TG(48:1) [M+K]+MG 20:0; [M+NH4]+MG 18:3; [M+NH4]+Cholesterol [M+H-H2O]+TG(56:5) C [M+Na]+MG 21:0; [M+NH4]+AC 12:2; [M]+TG 48:1; TG(16:0/16:0/16:1); [M+Na]+PA 29:6; [M+Na2-H]+PC(40:7) B [M+H]+PE 37:1; [M+Na]+AC 13:0; [M]+PA 46:0; [M+Na]+PC 27:0; [M+H]+lysoPC 10:0; [M+H]+TG 54:4; TG(18:1/18:1/18:2); [M+Na]+PC(38:5) B [M+H]+AC 9:0; [M]+CE(18:1) [M+Na]+TG 46:1; TG(14:0/16:0/16:1); [M+Na]+TG(54:2) [M+Na]+PA 6:0; [M+Na]+AC 13:1; [M]+MG 20:2; [M+NH4]+DG 34:1; [M+NH4]+MG 22:2; [M+NH4]+TG(49:1) [M+Na]+AC(8:0) [M+H]+MG 15:1; [M+NH4]+SM(d42:2) [M+H]+MG 14:1; [M+NH4]+MG 18:1; [M+NH4]+PC(38:3) [M+H]+AC 14:0; [M]+TG(54:3) [M+NH4]+PC 26:6; [M+Na]+EtherPC 32:0e; PC(14:0e/18:0); [M+H]+AC 14:3; [M]+AC(14:2) [M+H]+MG 3:0; [M+NH4]+SM d42:1; SM(d14:1/28:0); [M+H]+PE 35:0; [M+Na]+TG 54:6; TG(18:2/18:2/18:2); [M+Na]+PE(p-34:1)/PE(o-34:2) [M+H]+SM d34:1; SM(d14:1/20:0); [M+H]+PA 28:3; [M+Na2-H]+TG(60:2) [M+NH4]+TG(56:2) [M+NH4]+PC(38:2) [M+H]+PC 36:4; PC(18:2/18:2); [M+H]+PC 10:0; [M+H]+PC(38:4) C [M+H]+PC 32:0; PC(16:0/16:0); [M+H]+DG 17:0; [M+NH4]+PE 33:1; PE(16:0/17:1); [M+H]+CerP 20:0; [M+H]+SM(d40:2) B [M+H]+MG 17:0; [M+NH4]+AC 11:0; [M]+PC 33:1; [M+H]+PC(38:5) A [M+H]+MG 15:0; [M+NH4]+MG 19:0; [M+NH4]+PC(36:5) D [M+H]+PE 35:1; PE(16:0/19:1); [M+H]+PC(40:6)B [M+H]+AC(12:0) [M+H]+TG 58:4; [M+NH4]+PE(34:2)[M+H]+AC 11:1; [M]+TG(49:0) [M+Na]+TG 52:4; TG(16:0/18:2/18:2); [M+Na]+lysoPC 3:0; [M+Na]+CE(18:2) [M+Na]+TG(56:3) [M+NH4]+lysoPC 3:0; [M+H]+AC(10:1) [M+H]+lysoPE 4:0; [M+Na]+urinary levels, Painful Bladder Syndrome, Bladder, IC/BPS, chronic interstitial cystitis, ulcerative cystitis, interstitial cystitis/bladder pain syndrome, Chronic Interstitial Cystitides, Pain Syndrome, chronic interstitial cystitis (disorder), Metabonomic, Metabonomics, Interstitial Cystitis, Interstitial, Client, interstitial cystitis, chronic, Cystitis, Interstitial cystitis, Cystitides, Bladder Pain Syndromes, Patient, urinary aspects, Interstitial Cystitides, Clients, Chronic Interstitial Cystitis, chronic interstitial cystitis (disorder) [Ambiguous], interstitial cystitis/painful bladder syndrome, Chronic, IC/PBS, painful bladder syndrome, bladder pain syndrome, Metabolomic., chronic interstitial cystitis NOS (disorder), Bladder Pain Syndrome, Chronic Interstitialiones., Ionen, ion, Ion, ionsfalseIdentification of urine metabolites in patients with interstitial cystitis using untargeted metabolomics (part I)ST0011219606